RFA-NS-23-006 - HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Change to correct ORIPs listing under Components of Participating Organizations for PA-23-080, PA-23-230, PA-23-232, PAR-23-138, RFA-NS-23-006, and RFA-NS-23-007 | NOT-OD-23-172 | ORIP | Sep 6, 2023 | n/a | R41/R42, R43/R44, S10, T35 |
Notice of NHLBI Specific Interests and Guidance in RFA-NS-23-006 "HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)" | NOT-HL-22-050 | NHLBI | Sep 27, 2022 | n/a | R43/R44 |